bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Materials 1 from Establishment of the Cancer Prevention Study II Nutrition Cohort Colorectal Tissue Repository
Authors: Campbell Peter T. , Deka Anusila , Briggs Peter , Cicek Mine , Farris Alton B. , Gaudet Mia M. , Jacobs Eric J. , Newton Christina C. , Patel Alpa V. , Teras Lauren R. , Thibodeau Stephen N. , Tillmans Lori , Gapstur Susan M.
Published: April 2023

Documents sent to participants or spouses to obtain informed consent for participating in the Cancer Prevention Study-II Nutrition Cohort Colorectal Tissue Repository.
Supplementary Materials from Estimating TP53 Mutation Carrier Probability in Families with Li–Fraumeni Syndrome Using LFSPRO
Authors: Peng Gang , Bojadzieva Jasmina , Ballinger Mandy L. , Li Jialu , Blackford Amanda L. , Mai Phuong L. , Savage Sharon A. , Thomas David M. , Strong Louise C. , Wang Wenyi
Published: April 2023

Medical records and death certificates were used to confirm cancers where possible, with success in 77% and 6%, respectively, for an overall confirmation rate of 83% in the MDACC cohort.
Supplementary Table 2 from Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study
Authors: Flanagan James M. , Brook Mark N. , Orr Nick , Tomczyk Katarzyna , Coulson Penny , Fletcher Olivia , Jones Michael E. , Schoemaker Minouk J. , Ashworth Alan , Swerdlow Anthony , Brown Robert , Garcia-Closas Montserrat
Published: April 2023

Supplementary Table 2. ICC and association between weight and methylation levels for probes with P<10-5.
Supplementary Tables 1-3 from The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test
Authors: Schiffman Mark , Boyle Sean , Raine-Bennett Tina , Katki Hormuzd A. , Gage Julia C. , Wentzensen Nicolas , Kornegay Janet R. , Apple Raymond , Aldrich Carrie , Erlich Henry A. , Tam Thanh , Befano Brian , Burk Robert D. , Castle Philip E.
Published: April 2023

Supplementary Tables 1-3. Supplementary Table 1. Use of cobas-like partial HPV typing in triage of ASC-US. Supplementary Table 2. Use of cobas-like partial HPV typing in co-testing. Supplementary Table 3. Use of cobas-like partial HPV typing in primary HPV testing
Supplementary Table 1 from Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study
Authors: Flanagan James M. , Brook Mark N. , Orr Nick , Tomczyk Katarzyna , Coulson Penny , Fletcher Olivia , Jones Michael E. , Schoemaker Minouk J. , Ashworth Alan , Swerdlow Anthony , Brown Robert , Garcia-Closas Montserrat
Published: April 2023

Supplementary Table 1. Replication of age-associated probes in Florath et al. (31).
Supplementary tables 1-3, materials and methods, and supplementary figures 1 - 3. from Coffee Drinking and Risk of Lung Cancer—A Meta-Analysis
Authors: Galarraga Vania , Boffetta Paolo
Published: April 2023

Supplemental Table 1. Characteristics of the studies included in the meta-analysis. Supplemental Table 2. Pooled analysis using random effects model for ever vs. never coffee drinking, stratified by study design. Supplemental Table 3. Pooled analysis using random effects model for ever vs. never coffee drinking,stratified by region. Supplementary Materials and Methods. Supplemental Figure 1. Pooled analysis forest plot adjusting for smoking, stratified by gender Men. Supplemental Figure 2. Forest plot for all non-smokers, stratified by gender. Supplemental Figure 3. Funnel Plot.
Supplementary Figure Legends from Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study
Authors: Flanagan James M. , Brook Mark N. , Orr Nick , Tomczyk Katarzyna , Coulson Penny , Fletcher Olivia , Jones Michael E. , Schoemaker Minouk J. , Ashworth Alan , Swerdlow Anthony , Brown Robert , Garcia-Closas Montserrat
Published: April 2023

Supplementary Figure and Table Legends
Supplementary Figure 4 from Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study
Authors: Flanagan James M. , Brook Mark N. , Orr Nick , Tomczyk Katarzyna , Coulson Penny , Fletcher Olivia , Jones Michael E. , Schoemaker Minouk J. , Ashworth Alan , Swerdlow Anthony , Brown Robert , Garcia-Closas Montserrat
Published: April 2023

Supplementary Figure 4. Q-Q plots for associations between DNA methylation M-values and various subject characteristics, using standard regression analyses, SVA-adjusted analyses, and analyses adjusting for cell type.
Supplementary Figure 2 from Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study
Authors: Flanagan James M. , Brook Mark N. , Orr Nick , Tomczyk Katarzyna , Coulson Penny , Fletcher Olivia , Jones Michael E. , Schoemaker Minouk J. , Ashworth Alan , Swerdlow Anthony , Brown Robert , Garcia-Closas Montserrat
Published: April 2023

Supplementary Figure 2. Associations between DNA methylation probes and weight
Supplemental Figure 1 from Updated Review of Prevalence of Major Risk Factors and Use of Screening Tests for Cancer in the United States
Authors: Sauer Ann Goding , Siegel Rebecca L. , Jemal Ahmedin , Fedewa Stacey A.
Published: April 2023

sun protection behaviors
Supplemental Table 1 from Do Environmental Factors Modify the Genetic Risk of Prostate Cancer?
Authors: Loeb Stacy , Peskoe Sarah B. , Joshu Corinne E. , Huang Wen-Yi , Hayes Richard B. , Carter H. Ballentine , Isaacs William B. , Platz Elizabeth A.
Published: April 2023

Supplemental Table 1. 20 single nucleotide polymorphisms (SNPs) previously associated with prostate cancer susceptibility used to create a genetic risk score
Supplementary Tables and Figures from Obesity and the Incidence of Upper Gastrointestinal Cancers: An Ecological Approach to Examine Differences across Age and Sex
Authors: Arnold Melina , Colquhoun Amy , Cook Michael B. , Ferlay Jacques , Forman David , Soerjomataram Isabelle
Published: April 2023

Supplementary Table 1. Included countries according to obesity prevalence (proportion of body mass index{greater than or equal to}30kg/m2) quartiles in 2008 by sex. Supplementary Table 2a. Countries by obesity (proportion of body mass index{greater than or equal to}30kg/m2) and smoking (approximated by lung cancer mortality in 2012) tertiles, males. Supplementary Table 2b. Countries by obesity (proportion of body mass index{greater than or equal to}30kg/m2) and smoking (approximated by lung cancer mortality in 2012) tertiles, females. Supplementary Table 3. Age-standardized incidence rate ratios by smoking (approximated by age-standardized lung cancer mortality in 2012) and obesity prevalence (proportion of body mass index{greater than or equal to}30kg/m2) in tertiles (1-3, from lowest to highest), using 1st tertile (lowest level of exposure to both risk factors) as reference. Supplementary Figure 1. Age-standardized incidence rates (ASR) of esophageal and gastric cancers by sex and obesity (proportion of body mass index{greater than or equal to}30kg/m2) quartile, excluding China, Japan and Korea. Supplementary Figure 2. Age-specific incidence rates of esophageal and gastric cancers by sex and obesity (proportion of body mass index{greater than or equal to}30kg/m2) quartile, excluding China, Japan and Korea. Supplementary Figure 3. Male-to-female ratios of esophageal and gastric cancer by age and obesity (proportion of body mass index{greater than or equal to}30kg/m2) quartile, excluding China, Japan and Korea. Supplementary Figure 4. Correlations between obesity prevalence (%) and age-standardized incidence of esophageal and gastric cancers by sex.
Supplementary Tables 1-5, Supplementary Figures 1-4 from Prostate Cancer Risk Allele Specific for African Descent Associates with Pathologic Stage at Prostatectomy
Authors: Whitman Eric J. , Pomerantz Mark , Chen Yongmei , Chamberlin Michael M. , Furusato Bungo , Gao Chunling , Ali Amina , Ravindranath Lakshmi , Dobi Albert , Sestrehenn Isabell A. , McLeod David G. , Srivastava Shiv , Freedman Matthew , Petrovics Gyorgy
Published: April 2023

Supplementary Tables 1-5, Supplementary Figures 1-4 from Prostate Cancer Risk Allele Specific for African Descent Associates with Pathologic Stage at Prostatectomy
Supplementary Table 1 from Cigarette Experimentation in Mexican Origin Youth: Psychosocial and Genetic Determinants
Authors: Wilkinson Anna V. , Bondy Melissa L. , Wu Xifeng , Wang Jian , Dong Qiong , D'Amelio Anthony M. , Prokhorov Alexander V. , Pu Xia , Yu Robert K. , Etzel Carol J. , Shete Sanjay , Spitz Margaret R.
Published: April 2023

XLS - 104K
Supplementary Table S4 from Alcohol Intake and Risk of Incident Melanoma: A Pooled Analysis of Three Prospective Studies in the United States
Authors: Rivera Andrew , Nan Hongmei , Li Tricia , Qureshi Abrar , Cho Eunyoung
Published: April 2023

Multivariate-adjusted relative risks (RRs) for melanoma in situ according to beverage-specific alcohol intake in Nurses' Health Study (NHS), Nurses' Health Study II (NHSII) and Health Professionals Follow-Up Study (HPFS)
Supplementary Table S3 from Alcohol Intake and Risk of Incident Melanoma: A Pooled Analysis of Three Prospective Studies in the United States
Authors: Rivera Andrew , Nan Hongmei , Li Tricia , Qureshi Abrar , Cho Eunyoung
Published: April 2023

Age-adjusted and multivariate-adjusted RRs and pooled estimates for incident melanoma in situ by amount of average alcohol intake in Nurses' Health Study (NHS), Nurses' Health Study II (NHSII) and Health Professionals Follow-Up Study (HPFS)
Supplementary Table S2 from Alcohol Intake and Risk of Incident Melanoma: A Pooled Analysis of Three Prospective Studies in the United States
Authors: Rivera Andrew , Nan Hongmei , Li Tricia , Qureshi Abrar , Cho Eunyoung
Published: April 2023

Mean beverage-specific alcohol intake (g/d) according to average total alcohol intake in Nurses' Health Study (NHS), Nurses' Health Study II (NHSII) and Health Professionals Follow-Up Study (HPFS)
Supplementary Table 1 from Mental and Physical Health–Related Quality of Life among U.S. Cancer Survivors: Population Estimates from the 2010 National Health Interview Survey
Authors: Weaver Kathryn E. , Forsythe Laura P. , Reeve Bryce B. , Alfano Catherine M. , Rodriguez Juan L. , Sabatino Susan A. , Hawkins Nikki A. , Rowland Julia H.
Published: April 2023

PDF file - 75K, PROMIS Global Health Scale unadjusted means for cancer survivors and adults with no cancer history
Supplementary Tables 1-7 from Aspirin Use Reduces the Risk of Aggressive Prostate Cancer and Disease Recurrence in African-American Men
Authors: Smith Cheryl Jacobs , Dorsey Tiffany H. , Tang Wei , Jordan Symone V. , Loffredo Christopher A. , Ambs Stefan
Published: April 2023

Tables S1-S7. Table S1. Characteristics of all cases and population controls in the NCI Maryland Prostate Cancer Case-Control Study. Table S2. Pain reliever use of participants in the NCI Maryland Prostate Cancer Case-Control Study. Table S3. Adjusteda odds ratios and 95% confidence intervals for associations of regular aspirin use and prostate cancer risk in the NCI Maryland Prostate Cancer Case-Control Study. Table S4. Adjusteda odds ratios and 95% confidence intervals for associations of regular aspirin use and prostate cancer risk in men with low stageb disease compared to population controls. Table S5. Adjusteda odds ratios and 95% confidence intervals for associations of regular aspirin use and prostate cancer risk in men with high stageb disease compared to controls. Table S6. Adjusteda odds ratios and 95% Confidence intervals for associations of regular aspirin use and prostate cancer risk in men with aggressiveb disease compared to population controls. Table S7. Adjusteda odds ratios and 95% confidence intervals for associations of regular aspirin use and prostate cancer risk in men with nonaggressiveb disease compared to populations controls.
Supplemental Tables 1 - 3 from Mitochondrial DNA Copy Number and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Risk in Two Prospective Studies
Authors: Kim Christopher , Bassig Bryan A. , Seow Wei Jie , Hu Wei , Purdue Mark P. , Huang Wen-Yi , Liu Chin-San , Cheng Wen-Ling , Männistö Satu , Vermeulen Roel , Weinstein Stephanie J. , Lim Unhee , Hosgood H. Dean , Bonner Matthew R. , Caporaso Neil E. , Albanes Demetrius , Lan Qing , Rothman Nathaniel
Published: April 2023

Supplemental Table 1. Association of mtDNA copy number and risk of NHL subtypes and multiple myeloma by cohort Supplemental Table 2. Association of mtDNA copy number and risk of NHL in each cohort by sex and smoking status Supplemental Table 3. Association of mtDNA copy number and risk of NHL in each cohort stratified by diagnosis time from blood draw
Figure S3 from The Prevalence of Cancer-Associated Autoantibodies in Patients with Gastric Cancer and Progressive Grades of Premalignant Lesions
Authors: Meistere Irēna , Werner Simone , Zayakin Pawel , Siliņa Karīna , Rulle Undīne , Pismennaja Angelina , Šantare Daiga , Kikuste Ilze , Isajevs Sergejs , Leja Mārcis , Kupčinskas Limas , Kupčinskas Juozas , Jonaitis Laimas , Wu Chun-Ying , Brenner Hermann , Linē Aija , Kalniņa Zane
Published: April 2023

Supplementary Figure 3. Seroreactivity against individual HD-associated antigens.
Figure S1 from The Prevalence of Cancer-Associated Autoantibodies in Patients with Gastric Cancer and Progressive Grades of Premalignant Lesions
Authors: Meistere Irēna , Werner Simone , Zayakin Pawel , Siliņa Karīna , Rulle Undīne , Pismennaja Angelina , Šantare Daiga , Kikuste Ilze , Isajevs Sergejs , Leja Mārcis , Kupčinskas Limas , Kupčinskas Juozas , Jonaitis Laimas , Wu Chun-Ying , Brenner Hermann , Linē Aija , Kalniņa Zane
Published: April 2023

Supplementary Figure 1. Repeatability of the recombinant antigen microarray assay results.
Supplementary Table S1-S8 from Polymorphisms of a Disintegrin and Metalloproteinase with Thrombospondin Motifs 5 and Aflatoxin B1–Related Hepatocellular Carcinoma
Authors: Huang Xiao-Ying , Yao Jin-Guang , Huang Bing-Chen , Ma Yun , Xia Qiang , Long Xi-Dai
Published: April 2023

Supplementary Table S1 The polymorphisms information of ADAMTS5 and genotyping analysis. Supplementary Table S2 Demographic and Etiologic Characteristics of HCC Cases and Controls. Supplementary Table S3 Hardy-Weinberg equilibrium (HWE) test for ADAMTS5 genotypes among controls. Supplementary Table S4 ADAMTS5 polymorphisms and HCC risk. Supplementary Table S5 ADAMTS5 rs2830581 polymorphism and HCC risk stratified by matching factors (HBV and HCV infection, age, gender, and race). Supplementary Table S6. ADAMTS5 Polymorphism and Expression Levels of ADAMTS5 Protein. Supplementary Table S7 The ADAMTS5 rs2830581 polymorphism and the clinic-pathological features of HCC. Supplementary Table S8 The clinic-pathological features of HCC cases with or without TACE treat.
Supplementary Figure S2 from Polymorphisms of a Disintegrin and Metalloproteinase with Thrombospondin Motifs 5 and Aflatoxin B1–Related Hepatocellular Carcinoma
Authors: Huang Xiao-Ying , Yao Jin-Guang , Huang Bing-Chen , Ma Yun , Xia Qiang , Long Xi-Dai
Published: April 2023

The joint effects of both TACE treatment and ADAMTS5 rs2830581 genotypes in the 1299 HCC cases. In this analysis model, the combination of TACE treatment and ADAMTS5 genotypes was divided into six strata: Stratum 1, the combination of rs2830581-AA and TACE (-); Stratum 2, the combination of rs2830581-AA and TACE (+); Stratum 3, the combination of rs2830581-GA and TACE (-); Stratum 4, the combination of rs2830581-GA and TACE (+); Stratum 5, the combination of rs2830581-GG and TACE (-); and Stratum 6, the combination of rs2830581-GG and TACE (+). (A-B) Cumulative hazard function was plotted by Kaplan-Meier's methodology, and P value was calculated with two-sided log-rank tests. (C-D) Multiple cox regression analysis (including all known risk factors of Guangxiese HCC) was used to analysis the corresponding risk value of these binding variables.
Supplementary Table 1 from Insurance Status and Racial Disparities in Cancer-Specific Mortality in the United States: A Population-Based Analysis
Authors: Pan Hubert Y. , Walker Gary V. , Grant Stephen R. , Allen Pamela K. , Jiang Jing , Guadagnolo B. Ashleigh , Smith Benjamin D. , Koshy Matthew , Rusthoven Chad G. , Mahmood Usama
Published: April 2023

Multivariate Cox model for cancer-specific mortality with race-insurance interaction term
Supplementary Table 2 from Molecular Subtypes of Breast Cancer: Long-term Incidence Trends and Prognostic Differences
Authors: Valla Marit , Vatten Lars Johan , Engstrøm Monica Jernberg , Haugen Olav Anton , Akslen Lars Andreas , Bjørngaard Johan Håkon , Hagen Anne Irene , Ytterhus Borgny , Bofin Anna Mary , Opdahl Signe
Published: April 2023

Supplementary Table 2. Incidence rates and incidence rate ratios of breast cancer according to hormone and HER2 receptor status, age at diagnosis and year of birth. Observed and imputed estimates.
Supplemental Tables 1-3 from Overall and Abdominal Adiposity and Premenopausal Breast Cancer Risk among Hispanic Women: The Breast Cancer Health Disparities Study
Authors: John Esther M. , Sangaramoorthy Meera , Hines Lisa M. , Stern Mariana C. , Baumgartner Kathy B. , Giuliano Anna R. , Wolff Roger K. , Slattery Martha L.
Published: April 2023

Supplemental Tables 1-3. Supplemental Table 1: Characteristics of Study Population. Supplemental Table 2: Body Size Characteristics among Premenopausal Controls, by Ethnicity and Genetic Admixture among Hispanics. Supplemental Table 3: Height and Overall Adiposity Associations with ER+PR+ Breast Cancer in Premenopausal Hispanic Women, by Genetic Ancestry
Supplemenatary Figure 1 from Molecular Subtypes of Breast Cancer: Long-term Incidence Trends and Prognostic Differences
Authors: Valla Marit , Vatten Lars Johan , Engstrøm Monica Jernberg , Haugen Olav Anton , Akslen Lars Andreas , Bjørngaard Johan Håkon , Hagen Anne Irene , Ytterhus Borgny , Bofin Anna Mary , Opdahl Signe
Published: April 2023

Supplementary Figure 1. Breast cancer incidence rates according to age and year of birth. Blue lines: Women born before 1929. Red lines: Women born in 1929 or later. Dashed lines (red and blue) represent incidence rates of subtyped cases. Dotted lines (red and blue) represent incidence rates of cases with unknown subtype. Solid lines (red and blue) represent the total incidence rates (subtyped cases and cases with unknown subtype combined).
Supplementary Table 1 from Dietary Fat Intake During Adolescence and Breast Density Among Young Women
Authors: Jung Seungyoun , Goloubeva Olga , Klifa Catherine , LeBlanc Erin S. , Snetselaar Linda G. , Van Horn Linda , Dorgan Joanne F.
Published: April 2023

Fat intake during early adulthood
Supplemental Table 1 from Metabolic Syndrome and Risk of Endometrial Cancer in the United States: A Study in the SEER–Medicare Linked Database
Authors: Trabert Britton , Wentzensen Nicolas , Felix Ashley S. , Yang Hannah P. , Sherman Mark E. , Brinton Louise A.
Published: April 2023

Supplemental Table 1. Medicare claims data code definitions used to define metabolic syndrome factors.
Supplementary Figure S3 from Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium
Authors: Toth Reka , Scherer Dominique , Kelemen Linda E. , Risch Angela , Hazra Aditi , Balavarca Yesilda , Issa Jean-Pierre J. , Moreno Victor , Eeles Rosalind A. , Ogino Shuji , Wu Xifeng , Ye Yuanqing , Hung Rayjean J. , Goode Ellen L. , Ulrich Cornelia M.
Published: April 2023

Locuszoom plots of the regions with pleiotropic association. (A) TNP1 (2q35), (B) RUVBL1 and GATA2 (3q21), (C) PHC3 (3q26), (D) TET2 (4q24), (E) POU5F1, BAG6 and EHMT2 (6p21),(F) L3MBTL3 (6q23), (G) HDAC9 (7p21), (H) LOXL2 (8p21), (I) BRCA2 (13q12), (J) WDR61 and MORF4L1 (15q25), (K) TADA2A (17q12), (L) BABAM1 (19p13), (M) DPF1 (19q13) and (N) TGFB1 (19q13).
Supplementary Table 1 from Risk of Pancreatic Cancer in Breast Cancer Families from the Breast Cancer Family Registry
Authors: Mocci Evelina , Milne Roger L. , Méndez-Villamil Elena Yuste , Hopper John L. , John Esther M. , Andrulis Irene L. , Chung Wendy K. , Daly Mary , Buys Saundra S. , Malats Nuria , Goldgar David E.
Published: April 2023

XLS file - 37 KB, 4.Assumed penetrance and incidence for female BRCA1 and BRCA2: Assumed model for BRCA1 and BRCA2 inheritance used in the calculation of carrier probabilities.
Description of calibration process from Lung Cancer Detectability by Test, Histology, Stage, and Gender: Estimates from the NLST and the PLCO Trials
Authors: ten Haaf Kevin , van Rosmalen Joost , de Koning Harry J.
Published: April 2023

Overview of the calibration process.
Editorial from Primary hrHPV DNA Testing in Cervical Cancer Screening: How to Manage Screen-Positive Women? A POBASCAM Trial Substudy
Authors: Dijkstra Maaike G. , van Niekerk Dirk , Rijkaart Dorien C. , van Kemenade Folkert J. , Heideman Daniëlle A.M. , Snijders Peter J.F. , Meijer Chris J.L.M. , Berkhof Johannes
Published: April 2023

Editorial from Primary hrHPV DNA Testing in Cervical Cancer Screening: How to Manage Screen-Positive Women? A POBASCAM Trial Substudy
Supplemental Table S3 from EGFR Mutation Status and First-Line Treatment in Patients with Stage III/IV Non–Small Cell Lung Cancer in Germany: An Observational Study
Authors: Schuette Wolfgang , Schirmacher Peter , Eberhardt Wilfried Ernst Erich , Fischer Juergen R. , von der Schulenburg J.-Matthias Graf , Mezger Joerg , Schumann Christian , Serke Monika , Zaun Silke , Dietel Manfred , Thomas Michael
Published: April 2023

Supplemental Table S3. Tissue source and testing method used for EGFR mutation analysis
Supplemental Table 1 from Racial/Ethnic Differences in the Impact of Neighborhood Social and Built Environment on Breast Cancer Risk: The Neighborhoods and Breast Cancer Study
Authors: Conroy Shannon M. , Shariff-Marco Salma , Koo Jocelyn , Yang Juan , Keegan Theresa H.M. , Sangaramoorthy Meera , Hertz Andrew , Nelson David O. , Cockburn Myles , Satariano William A. , Yen Irene H. , Ponce Ninez A. , John Esther M. , Gomez Scarlett Lin
Published: April 2023

Associations between neighborhood contextual characteristics and breast cancer risk by race/ethnicity and nativity, the Neighborhoods and Breast Cancer Study, 1995-2002.
Supplementary Table S7 from A Randomized Double-Blind Placebo-Controlled Trial of the Effect of Vitamin D3 Supplementation on Breast Density in Premenopausal Women
Authors: Brisson Jacques , Bérubé Sylvie , Diorio Caroline , Mâsse Benoît , Lemieux Julie , Duchesne Thierry , Delvin Edgar , Vieth Reinhold , Yaffe Martin J. , Chiquette Jocelyne
Published: April 2023

Supplementary Table S7 shows the comparison of change in dense or non-dense areas of breast tissue on mammogram after the one-year intervention between arms receiving vitamin D3 with placebo - Post-hoc analysis
Supplemental Table 1 from Body Mass Index Is Associated with Gene Methylation in Estrogen Receptor–Positive Breast Tumors
Authors: Hair Brionna Y. , Troester Melissa A. , Edmiston Sharon N. , Parrish Eloise A. , Robinson Whitney R. , Wu Michael C. , Olshan Andrew F. , Swift-Scanlan Theresa , Conway Kathleen
Published: April 2023

Supplemental Table 1. Correlation between BMI-associated methylation sites (overall and among ER-positive tumors) and gene expression in breast tumors from The Cancer Genome Atlas (TCGA)
Supplementary Table S6 from A Randomized Double-Blind Placebo-Controlled Trial of the Effect of Vitamin D3 Supplementation on Breast Density in Premenopausal Women
Authors: Brisson Jacques , Bérubé Sylvie , Diorio Caroline , Mâsse Benoît , Lemieux Julie , Duchesne Thierry , Delvin Edgar , Vieth Reinhold , Yaffe Martin J. , Chiquette Jocelyne
Published: April 2023

Supplementary Table S6 shows the comparison of trends in mean change in percent mammographic breast density after the one-year intervention among arms receiving vitamin D3 or placebo, according to baseline characteristics - Per protocol analysis
Supplementary Table S5 from A Randomized Double-Blind Placebo-Controlled Trial of the Effect of Vitamin D3 Supplementation on Breast Density in Premenopausal Women
Authors: Brisson Jacques , Bérubé Sylvie , Diorio Caroline , Mâsse Benoît , Lemieux Julie , Duchesne Thierry , Delvin Edgar , Vieth Reinhold , Yaffe Martin J. , Chiquette Jocelyne
Published: April 2023

Supplementary Table S5 shows the comparison of change in percent mammographic breast density after the one-year intervention between arms receiving vitamin D3 with placebo - Per protocol analysis
Supplementary Table S2 from The Cost-Effectiveness of Visual Triage of Human Papillomavirus–Positive Women in Three Low- and Middle-Income Countries
Authors: Campos Nicole G. , Jeronimo Jose , Tsu Vivien , Castle Philip E. , Mvundura Mercy , Kim Jane J.
Published: April 2023

Sensitivity analyses for 2-visit HPV versus 2-visit HPV-VIA in Uganda
Supplementary Table S2 from A Randomized Double-Blind Placebo-Controlled Trial of the Effect of Vitamin D3 Supplementation on Breast Density in Premenopausal Women
Authors: Brisson Jacques , Bérubé Sylvie , Diorio Caroline , Mâsse Benoît , Lemieux Julie , Duchesne Thierry , Delvin Edgar , Vieth Reinhold , Yaffe Martin J. , Chiquette Jocelyne
Published: April 2023

Supplementary Table S2 shows the comparison of change in serum 25(OH)D3 after the one-year intervention between arms receiving vitamin D3 with placebo
Supplementary Table 1 from The Cost-Effectiveness of Visual Triage of Human Papillomavirus–Positive Women in Three Low- and Middle-Income Countries
Authors: Campos Nicole G. , Jeronimo Jose , Tsu Vivien , Castle Philip E. , Mvundura Mercy , Kim Jane J.
Published: April 2023

Sensitivity analyses for 2-visit HPV versus 2-visit HPV-VIA in Nicaragua
Supplementary Figure Legend from Where Can Colorectal Cancer Screening Interventions Have the Most Impact?
Authors: Siegel Rebecca L. , Sahar Liora , Robbins Anthony , Jemal Ahmedin
Published: April 2023

Supplementary Figure Legend from Where Can Colorectal Cancer Screening Interventions Have the Most Impact?
Supplementary Table 1 from Circulating 25-Hydroxyvitamin D3 and Survival after Diagnosis with Kidney Cancer
Authors: Muller David C. , Scelo Ghislaine , Zaridze David , Janout Vladimir , Holcatova Ivana , Navratilova Marie , Mates Dana , Midttun Øivind , Ueland Per Magne , Brennan Paul , Johansson Mattias
Published: April 2023

Supplementary Table 1. Demographic and clinical characteristics of the participants for those included and not included in the case-cohort sample
Supplementary Figure 1 from Circulating 25-Hydroxyvitamin D3 and Survival after Diagnosis with Kidney Cancer
Authors: Muller David C. , Scelo Ghislaine , Zaridze David , Janout Vladimir , Holcatova Ivana , Navratilova Marie , Mates Dana , Midttun Øivind , Ueland Per Magne , Brennan Paul , Johansson Mattias
Published: April 2023

Supplementary Figure 1. Hazard ratios (HR) and 95% confidence intervals (CI) for a doubling in season-adjusted 25(OH)D3 concentration by potential effect modifiers.
Supplementary Figure 1 caption from Circulating 25-Hydroxyvitamin D3 and Survival after Diagnosis with Kidney Cancer
Authors: Muller David C. , Scelo Ghislaine , Zaridze David , Janout Vladimir , Holcatova Ivana , Navratilova Marie , Mates Dana , Midttun Øivind , Ueland Per Magne , Brennan Paul , Johansson Mattias
Published: April 2023

Supplementary Figure 1 caption
Supplementary Table 1 from Tissue and Serum Mesothelin Are Potential Markers of Neoplastic Progression in Barrett's Associated Esophageal Adenocarcinoma
Authors: Rizk Nabil P. , Servais Elliot L. , Tang Laura H. , Sima Camelia S. , Gerdes Hans , Fleisher Martin , Rusch Valerie W. , Adusumilli Prasad S.
Published: April 2023

PDF file - 76K
supplemental Tables 1-5 from Body Size Throughout Adult Life Influences Postmenopausal Breast Cancer Risk among Hispanic Women: The Breast Cancer Health Disparities Study
Authors: John Esther M. , Sangaramoorthy Meera , Hines Lisa M. , Stern Mariana C. , Baumgartner Kathy B. , Giuliano Anna R. , Wolff Roger K. , Slattery Martha L.
Published: April 2023

supplemental Tables 1-5. Supplemental Table 1: Characteristics of Study Population. Supplemental Table 2: Body Size Characteristics among Postmenopausal Controls, by Ethnicity and Genetic Admixture among Hispanics. Supplemental Table 3: Abdominal Adiposity Associations with Breast Cancer Risk in Hispanic Postmenopausal Women Measured <12 Months after Diagnosis/Selection, by Use of Hormone Therapy. Supplemental Table 4: Abdominal Adiposity Associations with Breast Cancer Risk in NHW Postmenopausal Women Measured <12 Months after Diagnosis/Selection, by Use of Hormone Therapy. Supplemental Table 5: Overall Adiposity Associations with ER+PR+ Breast Cancer in Postmenopausal Hispanic Women not Currently Using Hormone Therapy, by Genetic Ancestry.
Supplemental Methods from Enterolignan-Producing Phenotypes Are Associated with Increased Gut Microbial Diversity and Altered Composition in Premenopausal Women in the United States
Authors: Hullar Meredith A.J. , Lancaster Samuel M. , Li Fei , Tseng Elizabeth , Beer Karlyn , Atkinson Charlotte , Wähälä Kristiina , Copeland Wade K. , Randolph Timothy W. , Newton Katherine M. , Lampe Johanna W.
Published: April 2023

Supplemental Methods
Supplemental Figure Legends from Enterolignan-Producing Phenotypes Are Associated with Increased Gut Microbial Diversity and Altered Composition in Premenopausal Women in the United States
Authors: Hullar Meredith A.J. , Lancaster Samuel M. , Li Fei , Tseng Elizabeth , Beer Karlyn , Atkinson Charlotte , Wähälä Kristiina , Copeland Wade K. , Randolph Timothy W. , Newton Katherine M. , Lampe Johanna W.
Published: April 2023

Supplemental Figure Legends
Supplemental Figure 3 from Enterolignan-Producing Phenotypes Are Associated with Increased Gut Microbial Diversity and Altered Composition in Premenopausal Women in the United States
Authors: Hullar Meredith A.J. , Lancaster Samuel M. , Li Fei , Tseng Elizabeth , Beer Karlyn , Atkinson Charlotte , Wähälä Kristiina , Copeland Wade K. , Randolph Timothy W. , Newton Katherine M. , Lampe Johanna W.
Published: April 2023

Supplemental Figure 3 - Box and whisker plots of the dominant bacteria in enterotype clusters 1, 2, or 3. Black dots are the means. Sum refers to the sum of the Pyramidobacter, Oscillibacter and Dethiosulfitibacter in Cluster 3.
Supplemental Figure 2 from Enterolignan-Producing Phenotypes Are Associated with Increased Gut Microbial Diversity and Altered Composition in Premenopausal Women in the United States
Authors: Hullar Meredith A.J. , Lancaster Samuel M. , Li Fei , Tseng Elizabeth , Beer Karlyn , Atkinson Charlotte , Wähälä Kristiina , Copeland Wade K. , Randolph Timothy W. , Newton Katherine M. , Lampe Johanna W.
Published: April 2023

Supplemental Figure 2 - Silhouette width for clusters.
Supplemental Tables S1-S2 from The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women
Authors: Cote Michele L. , Ruterbusch Julie J. , Olson Sara H. , Lu Karen , Ali-Fehmi Rouba
Published: April 2023

Supplementary Table S1: Annual percent change by subtype and race and ethnicity for endometrial cancers diagnosed 2000-2007, Surveillance, Epidemiology and End Results. Supplementary Table S2: 5 year relative survival by subtype, race and ethnicity, and stage for endometrial cancers diagnosed 2000-2007, Surveillance, Epidemiology and End Results.
Supplementary Table 1 from Colorectal Cancer Risk Following Adenoma Removal: A Large Prospective Population-Based Cohort Study
Authors: Coleman Helen G. , Loughrey Maurice B. , Murray Liam J. , Johnston Brian T. , Gavin Anna T. , Shrubsole Martha J. , Bhat Shivaram K. , Allen Patrick B. , McConnell Vivienne , Cantwell Marie M.
Published: April 2023

Supplementary Table 1. Sensitivity analysis excluding 1 year follow-up
Supplementary Material and Methods. Supplementary Tables 1 and 2. from Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program
Authors: Gage Julia C. , Hunt William C. , Schiffman Mark , Katki Hormuzd A. , Cheung Li C. , Cuzick Jack , Myers Orrin , Castle Philip E. , Wheeler Cosette M.
Published: April 2023

Supplementary Material and Methods. Supplemental Table 1. Kaplan-Meier estimates of 3- and 5-year cumulative risks of CIN2+ and CIN3+ among women by age and baseline screening result. Supplementary Table 2. Logistic-Weibull estimates of 3- and 5-year cumulative risks of CIN2+ and CIN3+ among women by age and baseline screening result.
Supplemental Table 1 from Statin Use and Breast Cancer Risk in the Nurses' Health Study
Authors: Borgquist Signe , Tamimi Rulla M. , Chen Wendy Y. , Garber Judy E. , Eliassen A. Heather , Ahern Thomas P.
Published: April 2023

Associations between specific statins and invasive breast cancer incidence, in the Nurses' Health Study among new initiators of statins 2004-2012.
Supplementary Table 3 from Benign Breast Tissue Composition in Breast Cancer Patients: Association with Risk Factors, Clinical Variables, and Gene Expression
Authors: Sun Xuezheng , Sandhu Rupninder , Figueroa Jonine D. , Gierach Gretchen L. , Sherman Mark E. , Troester Melissa A.
Published: April 2023

Supplementary Table 3 - Significant biological pathways of breast tissue composition signatures
Supplementary Table 1 from Nicotine Metabolite Ratio (3-Hydroxycotinine/Cotinine) in Plasma and Urine by Different Analytical Methods and Laboratories: Implications for Clinical Implementation
Authors: Tanner Julie-Anne , Novalen Maria , Jatlow Peter , Huestis Marilyn A. , Murphy Sharon E. , Kaprio Jaakko , Kankaanpää Aino , Galanti Laurence , Stefan Cristiana , George Tony P. , Benowitz Neal L. , Lerman Caryn , Tyndale Rachel F.
Published: April 2023

Supplementary Table 1. Detailed methods for measurement of plasma and urine COT and 3HC at each Test Site.
Supplementary Figure 2C from Fine-Mapping of IL16 Gene and Prostate Cancer Risk in African Americans
Authors: Batai Ken , Shah Ebony , Murphy Adam B. , Newsome Jennifer , Ruden Maria , Ahaghotu Chiledum , Kittles Rick A.
Published: April 2023

PDF file, 105K, LD plots of the 11 SNPs in 1000 genome YRI population.
Supplementary Table 1 from Germline Variation in Apoptosis Pathway Genes and Risk of Non–Hodgkin's Lymphoma
Authors: Kelly Jennifer L. , Novak Anne J. , Fredericksen Zachary S. , Liebow Mark , Ansell Stephen M. , Dogan Ahmet , Wang Alice H. , Witzig Thomas E. , Call Timothy G. , Kay Neil E. , Habermann Thomas M. , Slager Susan L. , Cerhan James R.
Published: April 2023

Supplementary Table 1 from Germline Variation in Apoptosis Pathway Genes and Risk of Non–Hodgkin's Lymphoma
Supplementary Figure 1 from Fine-Mapping of IL16 Gene and Prostate Cancer Risk in African Americans
Authors: Batai Ken , Shah Ebony , Murphy Adam B. , Newsome Jennifer , Ruden Maria , Ahaghotu Chiledum , Kittles Rick A.
Published: April 2023

PDF file, 117K, -Log10 P-value plot of genotyped SNPs in IL-16 (±250kb) region in Washington, D.C. AA discovery samples.
Supplementary Table 6 from Circulating Sex Hormones and Terminal Duct Lobular Unit Involution of the Normal Breast
Authors: Khodr Zeina G. , Sherman Mark E. , Pfeiffer Ruth M. , Gierach Gretchen L. , Brinton Louise A. , Falk Roni T. , Patel Deesha A. , Linville Laura M. , Papathomas Daphne , Clare Susan E. , Visscher Daniel W. , Mies Carolyn , Hewitt Stephen M. , Storniolo Anna Maria V. , Rosebrock Adrian , Caban Jesus J. , Figueroa Jonine D.
Published: April 2023

Supplementary Table 6 - Associations between serum prolactin levels and TDLU counts after stratification of parity in the KTB.
Supplemental Table 4 from Nut Consumption and Lung Cancer Risk: Results from Two Large Observational Studies
Authors: Lee Jennifer T. , Lai Gabriel Y. , Liao Linda M. , Subar Amy F. , Bertazzi Pier Alberto , Pesatori Angela C. , Freedman Neal D. , Landi Maria Teresa , Lam Tram Kim
Published: April 2023

Odds ratios and Hazard ratios (95% Confidence Intervals) for lung cancer and nut consumption in EAGLE and AARP, by smoking intensity
Suupplementary Tables S1-S7 from Dairy Consumption in Adolescence and Early Adulthood and Risk of Breast Cancer
Authors: Farvid Maryam S. , Eliassen A. Heather , Cho Eunyoung , Chen Wendy Y. , Willett Walter C.
Published: April 2023

Table S1: Definitions for early adulthood various dairy products subgroups.Table S2: Definitions for adolescent various dairy products subgroups. Table S3: Age-standardized characteristics in 1998 according to intake of total dairy products during adolescence among women enrolled in the Nursesâ€™ Health Study II. Table S4. Hazard ratios (HR) and 95% confidence intervals (95% CI) for breast cancer according to adolescent dairy product items.Table S5. Hazard ratios (HR) and 95% confidence intervals (95% CI) for breast cancer according to quintile of early adulthood dairy products items. Table S6. Hazard ratios (HR) and 95% confidence intervals (95%CI) for breast cancer according to quintile of adolescent calcium, vitamin D, and lactose intake. Table S7. Hazard ratios (HR) and 95% confidence intervals (95% CI) for breast cancer according to quintile of early adulthood calcium, vitamin D, and lactose intake.
Supplementary Table S1 from Prevalence of Human Papillomavirus in Cancer of the Oropharynx by Gender
Authors: Combes Jean-Damien , Chen Alyce A. , Franceschi Silvia
Published: April 2023

Supplementary Table S1. Characteristics of 63 studies evaluated for the prevalence of HPV markers in men and women.
Supplemental Figure S1 from The Contribution of Common Genetic Variation to Nicotine and Cotinine Glucuronidation in Multiple Ethnic/Racial Populations
Authors: Patel Yesha M. , Stram Daniel O. , Wilkens Lynne R. , Park Sung-Shim L. , Henderson Brian E. , Le Marchand Loic , Haiman Christopher A. , Murphy Sharon E.
Published: April 2023

Supplemental Figure S1. A) Manhattan plot of the -log10 (p-values) from the test of association for nicotine glucuronidation plotted as a function of the chromosomal position. Genome-wide significance is defined as the Bonferroni corrected 5% significance threshold (p-value<5.0Ã—10âˆ’8) and is indicated as a red line. B) Quantile-Quantile plot of the GWAS results for nicotine glucuronidation. C) Manhattan plot with the scale of the y-axis, the -log10 (p-values) reduced to 1.0Ã—10âˆ’20 for visual acuity of all significant associations. D) Manhattan plot of chromosome 4 specific -log10 (p-values) from the test of association for nicotine glucuronidation.
Supplementary Table S5 from Genetic Associations in Classical Hodgkin Lymphoma: A Systematic Review and Insights into Susceptibility Mechanisms
Authors: Kushekhar Kushi , van den Berg Anke , Nolte Ilja , Hepkema Bouke , Visser Lydia , Diepstra Arjan
Published: April 2023

Overview of genetic associations for classical Hodgkin lymphoma treatment related secondary malignancies and toxicities.
Supplementary table 3 from Cancer Risk in Women Treated with Fertility Drugs According to Parity Status—A Registry-based Cohort Study
Authors: Reigstad Marte Myhre , Storeng Ritsa , Myklebust Tor Åge , Oldereid Nan Birgitte , Omland Anne Katerine , Robsahm Trude Eid , Brinton Louise Annette , Vangen Siri , Furu Kari , Larsen Inger Kristin
Published: April 2023

Supplementary Table 3. Hazard ratios* (HR) and 95% confidence intervals (CI) of cancer in women receiving clomiphene citrate as registered in the Norwegian Prescription Database, stratified by cumulative doss of clomiphene citrate, (number of treatmet cycles of 50 mg x 5).
Supplemental Figure 2 from The Expression of Four Genes as a Prognostic Classifier for Stage I Lung Adenocarcinoma in 12 Independent Cohorts
Authors: Okayama Hirokazu , Schetter Aaron J. , Ishigame Teruhide , Robles Ana I. , Kohno Takashi , Yokota Jun , Takenoshita Seiichi , Harris Curtis C.
Published: April 2023

Supplemental Figure 2. The performance of the 4-coding gene classifier in 9 independent cohorts of stage I lung squamous cell carcinoma patients. The combined analysis uses the 8 cohorts for which overall survival data was available. For each cohort, cases were categorized as high, medium or low based on tertiles. P-values were obtained by the log-rank test for trend.
Supplementary Tables S1-S4 from Diagnostic Metabolomic Blood Tests for Endoluminal Gastrointestinal Cancer—A Systematic Review and Assessment of Quality
Authors: Antonowicz Stefan , Kumar Sacheen , Wiggins Tom , Markar Sheraz R. , Hanna George B.
Published: April 2023

Supplementary Table S1: QUADAS-2 assessment. Supplementary Table S2: Index test methodological quality Supplementary Table S3: STARD checklist assessment Supplementary Table S4: All significant metabolites
Supplementary Tables 1-3 from Differential and Joint Effects of Metformin and Statins on Overall Survival of Elderly Patients with Pancreatic Adenocarcinoma: A Large Population-Based Study
Authors: E Jian-Yu , Lu Shou-En , Lin Yong , Graber Judith M. , Rotter David , Zhang Lanjing , Petersen Gloria M. , Demissie Kitaw , Lu-Yao Grace , Tan Xiang-Lin
Published: April 2023

Supplementary Tables S1, S2, S3
Supplementary Table 1 from Risk Factors for Oral HPV Infection among a High Prevalence Population of HIV-Positive and At-Risk HIV-Negative Adults
Authors: Beachler Daniel C. , Weber Kathleen M. , Margolick Joseph B. , Strickler Howard D. , Cranston Ross D. , Burk Robert D. , Wiley Dorothy J. , Minkoff Howard , Reddy Susheel , Stammer Emily E. , Gillison Maura L. , D'Souza Gypsyamber
Published: April 2023

PDF file - 77K
Supplementary Figure 3 from Effects of Preanalytic Variables on Circulating MicroRNAs in Whole Blood
Authors: Zhao Hua , Shen Jie , Hu Qiang , Davis Warren , Medico Leonardo , Wang Dan , Yan Li , Guo Yuqing , Liu Biao , Qin Maochun , Nesline Mary , Zhu Qianqian , Yao Song , Ambrosone Christine B. , Liu Song
Published: April 2023

Supplementary Figure 3 - The effects of storage duration (baseline vs. 6 months) on the circulation level of miR-346 and miR-134 in whole blood of cases and controls, separately.
Supplementary Figure 1 from Effects of Preanalytic Variables on Circulating MicroRNAs in Whole Blood
Authors: Zhao Hua , Shen Jie , Hu Qiang , Davis Warren , Medico Leonardo , Wang Dan , Yan Li , Guo Yuqing , Liu Biao , Qin Maochun , Nesline Mary , Zhu Qianqian , Yao Song , Ambrosone Christine B. , Liu Song
Published: April 2023

Supplementary Figure 1 - The effects of processing delay time (no delay vs. 24 hours delay) on the circulation level of miR-346 and miR-134 in whole blood of cases and controls, separately.
Annual Percent Change from Cancer Incidence and Survival Trends by Subtype Using Data from the Surveillance Epidemiology and End Results Program, 1992–2013
Authors: Noone Anne-Michelle , Cronin Kathleen A. , Altekruse Sean F. , Howlader Nadia , Lewis Denise R. , Petkov Valentina I. , Penberthy Lynne
Published: April 2023

Results from the Joinpoint models
Supplementary Figure S1 from Confounding of the Association between Radiation Exposure from CT Scans and Risk of Leukemia and Brain Tumors by Cancer Susceptibility Syndromes
Authors: Meulepas Johanna M. , Ronckers Cécile M. , Merks Johannes , Weijerman Michel E. , Lubin Jay H. , Hauptmann Michael
Published: April 2023

Estimated potential bias of the relative risk for a brain tumor among high versus low exposed subjects by failure to adjust for neurofibromatosis type I (NF1)
Supplementary Figure 1 from Genetic Polymorphisms in Pre-microRNA Genes as Prognostic Markers of Colorectal Cancer
Authors: Xing Jinliang , Wan Shaogui , Zhou Feng , Qu Falin , Li Bingshan , Myers Ronald E. , Fu Xiaoying , Palazzo Juan P. , He Xianli , Chen Zhinan , Yang Hushan
Published: April 2023

PDF file - 101K
Supplementary Tables 1-2 from Chemotherapy and Thyroid Cancer Risk: A Report from the Childhood Cancer Survivor Study
Authors: Veiga Lene H.S. , Bhatti Parveen , Ronckers Cécile M. , Sigurdson Alice J. , Stovall Marilyn , Smith Susan A. , Weathers Rita , Leisenring Wendy , Mertens Ann C. , Hammond Sue , Neglia Joseph P. , Meadows Anna T. , Donaldson Sarah S. , Sklar Charles A. , Friedman Debra L. , Robison Leslie L. , Inskip Peter D.
Published: April 2023

PDF file - 82K
Supplementary Table 3 from Association of Parity and Time since Last Birth with Breast Cancer Prognosis by Intrinsic Subtype
Authors: Sun Xuezheng , Nichols Hazel B. , Tse Chiu-Kit , Bell Mary B. , Robinson Whitney R. , Sherman Mark E. , Olshan Andrew F. , Troester Melissa A.
Published: April 2023

HRs of all-cause mortality associated with parity and birth recency, in the CBCS Phases I and II
Supplementary Table 2 from Association of Parity and Time since Last Birth with Breast Cancer Prognosis by Intrinsic Subtype
Authors: Sun Xuezheng , Nichols Hazel B. , Tse Chiu-Kit , Bell Mary B. , Robinson Whitney R. , Sherman Mark E. , Olshan Andrew F. , Troester Melissa A.
Published: April 2023

Characteristics of study population by last birth recency group, in the CBCS Phases I and II
Supplementary Table 1 from Association of Parity and Time since Last Birth with Breast Cancer Prognosis by Intrinsic Subtype
Authors: Sun Xuezheng , Nichols Hazel B. , Tse Chiu-Kit , Bell Mary B. , Robinson Whitney R. , Sherman Mark E. , Olshan Andrew F. , Troester Melissa A.
Published: April 2023

Characteristics of study population by parity, in the CBCS Phases I and II.
Table S4 from Impact of Sixteen Established Pancreatic Cancer Susceptibility Loci in American Jews
Authors: Streicher Samantha A. , Klein Alison P. , Olson Sara H. , Amundadottir Laufey T. , DeWan Andrew T. , Zhao Hongyu , Risch Harvey A.
Published: April 2023

Supplementary Tables 4a-4d
Table S1 from Impact of Sixteen Established Pancreatic Cancer Susceptibility Loci in American Jews
Authors: Streicher Samantha A. , Klein Alison P. , Olson Sara H. , Amundadottir Laufey T. , DeWan Andrew T. , Zhao Hongyu , Risch Harvey A.
Published: April 2023

Supplementary Table 1
Figure S2 from Impact of Sixteen Established Pancreatic Cancer Susceptibility Loci in American Jews
Authors: Streicher Samantha A. , Klein Alison P. , Olson Sara H. , Amundadottir Laufey T. , DeWan Andrew T. , Zhao Hongyu , Risch Harvey A.
Published: April 2023

Supplementary Figures 2a-2d
Supplementary Table 1: Measures of adiposity and the risk of HNC among EPIC participants, including adjustment for weight change after baseline from Measured Adiposity in Relation to Head and Neck Cancer Risk in the European Prospective Investigation into Cancer and Nutrition
Authors: Ward Heather A. , Wark Petra A. , Muller David C. , Steffen Annika , Johansson Mattias , Norat Teresa , Gunter Marc J. , Overvad Kim , Dahm Christina C. , Halkjær Jytte , Tjønneland Anne , Boutron-Ruault Marie-Christine , Fagherazzi Guy , Mesrine Sylvie , Brennan Paul , Freisling Heinz , Li Kuanrong , Kaaks Rudolf , Trichopoulou Antonia , Lagiou Pagona , Panico Salavatore , Grioni Sara , Tumino Rosario , Vineis Paolo , Palli Domenico , Peeters Petra H.M. , Bueno-de-Mesquita H. Bas. , Weiderpass Elisabete , Agudo Antonio , Quirós Jose Ramón , Larrañaga Nerea , Ardanaz Eva , Huerta José María , Sánchez María-José , Laurell Göran , Johansson Ingegerd , Westin Ulla , Wallström Peter , Bradbury Kathryn E. , Wareham Nicholas J. , Khaw Kay-Tee , Pearson Clare , Boeing Heiner , Riboli Elio
Published: April 2023

Measures of adiposity and the risk of HNC among EPIC participants, including adjustment for weight change after baseline
Supplementary Figure 1: Scatterplots of the associations between BMI (kg/m2) and WC (Fig 1a) and between BMI (kg/m2) and WHR (Fig 1b). from Measured Adiposity in Relation to Head and Neck Cancer Risk in the European Prospective Investigation into Cancer and Nutrition
Authors: Ward Heather A. , Wark Petra A. , Muller David C. , Steffen Annika , Johansson Mattias , Norat Teresa , Gunter Marc J. , Overvad Kim , Dahm Christina C. , Halkjær Jytte , Tjønneland Anne , Boutron-Ruault Marie-Christine , Fagherazzi Guy , Mesrine Sylvie , Brennan Paul , Freisling Heinz , Li Kuanrong , Kaaks Rudolf , Trichopoulou Antonia , Lagiou Pagona , Panico Salavatore , Grioni Sara , Tumino Rosario , Vineis Paolo , Palli Domenico , Peeters Petra H.M. , Bueno-de-Mesquita H. Bas. , Weiderpass Elisabete , Agudo Antonio , Quirós Jose Ramón , Larrañaga Nerea , Ardanaz Eva , Huerta José María , Sánchez María-José , Laurell Göran , Johansson Ingegerd , Westin Ulla , Wallström Peter , Bradbury Kathryn E. , Wareham Nicholas J. , Khaw Kay-Tee , Pearson Clare , Boeing Heiner , Riboli Elio
Published: April 2023

Scatterplots of the associations between BMI (kg/m2) and WC (Fig 1a) and between BMI (kg/m2) and WHR (Fig 1b).